Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 05 Mar 2015 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Bank history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | SBI Banking & Financial Services Fund |
|---|---|
| 05 Mar 2015 | ₹100.00 |
| 17 Feb 2016 | ₹80.19 |
| 31 Jan 2017 | ₹112.57 |
| 15 Jan 2018 | ₹153.98 |
| 29 Dec 2018 | ₹161.50 |
| 13 Dec 2019 | ₹195.44 |
| 26 Nov 2020 | ₹195.12 |
| 10 Nov 2021 | ₹257.41 |
| 25 Oct 2022 | ₹256.96 |
| 09 Oct 2023 | ₹276.17 |
| 21 Sep 2024 | ₹386.96 |
| 05 Sep 2025 | ₹407.70 |
| 20 Aug 2026 | ₹426.26 |
| Metric | SBI · Regular NAV ₹43.64 Very High risk ★★★★☆ | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| +2.13% | +5.83% | |
| +16.33% | +15.63% | |
| +12.94% | +13.23% | |
| +14.02% | +13.85% | |
| +13.49% | +12.26% | |
| +13.30% | — | |
| +15.69% | +15.60% | |
| +14.69% | +14.52% | |
| +16.26% | +13.74% | |
| Risk | ||
| 15.52% | 15.62% | |
| 0.63 | 0.43 | |
| 0.88 | 0.59 | |
| -43.85% | -23.65% | |
| Nifty Bank | — | |
| +6.50% | +3.42% | |
| 0.81 | 0.95 | |
| 95.5% | 105.9% | |
| 56.7% | 93.6% | |
| 2.15% | 2.39% | |
| ₹10,872Cr | ₹1,161Cr | |
| 0.50% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 33% | 45% | |
| Milind Agrawal · 7.1y | — | |
| 05 Mar 2015 | — | |
| 32 | — | |
| 71.6% | — | |
| 1.8% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.